Lurtotecan Completed Phase 1 Trials for Lung Cancer / Unspecified Adult Solid Tumor, Protocol Specific / Ovarian Cancer / Head And Neck Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00006036Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors